Device Authority targets a core security gap in healthcare

Tern plc

Legacy medical devices are not disappearing from healthcare networks. Many hospitals still depend on older equipment that remains clinically useful, expensive to replace and difficult to take offline. That reality creates a clear security challenge: connected medical devices need to be protected even when they were not designed for today’s cybersecurity demands.

Device Authority argues that healthcare organisations need an identity-first security strategy to manage this risk. It is not enough to know that a device is connected to a network. Healthcare providers need to know what the device is, whether it can be trusted, whether its credentials are valid and whether it should be allowed to communicate with other systems.

Many legacy medical devices were built before modern security standards became common. Some may lack strong authentication. Others may rely on outdated software, limited update options or weak certificate management. In a hospital setting, these weaknesses can be difficult to fix quickly because the devices may support critical services and cannot always be replaced or patched without affecting clinical operations.

An identity-first approach puts the device itself at the centre of the security model. Each device needs a trusted identity that can be issued, managed, renewed and revoked across its lifecycle. This makes it easier to control access, reduce exposure and support compliance without depending only on network-based defences. It also gives healthcare organisations a more practical way to manage risk across mixed estates of new and old devices.

For Device Authority, the message is commercially relevant. Healthcare is a sector where connected-device security is not optional, but replacement cycles are long and operational disruption carries real consequences.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search